Description
SYNJARDY is a medication used to treat type 2 diabetes. It is a combination of two active ingredients: empagliflozin and metformin. Empagliflozin belongs to a class of drugs called SGLT2 inhibitors, which work by helping the kidneys remove glucose from the bloodstream through urine, thus lowering blood sugar levels. Metformin belongs to the biguanide class of medications and works primarily by decreasing the amount of glucose produced by the liver and improving the body’s response to insulin. By combining these two medications, SYNJARDY helps control blood sugar levels in people with type 2 diabetes.
As with any medication, it’s essential to use SYNJARDY under the supervision of a healthcare provider and to follow their instructions regarding dosage and usage. Additionally, individuals taking SYNJARDY should be aware of potential side effects and interactions with other medications. It’s important to discuss any concerns or questions with a healthcare professional before starting or making changes to a diabetes treatment regimen.
